Topics

Shingles and HIV medications boost GSK first quarter sales

07:39 EDT 1 May 2019 | Financial Times

Drugmaker beats expectations but warns generic alternative to hit sales of asthma drug

Original Article: Shingles and HIV medications boost GSK first quarter sales

NEXT ARTICLE

More From BioPortfolio on "Shingles and HIV medications boost GSK first quarter sales"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...